Abstract
For an ever-increasing number of species, the completed genomic sequence is available, providing a means to identify all the genes encoded in a genome. The functional relationships between these genes must be defined in order to generate a cohesive understanding of the molecular events that direct metazoan development. The model organism C. elegans, with its completed genomic sequence, defined cell lineage and robust genetics, provides an excellent opportunity to reconstruct the genetic relationships that underlie the development of a relatively simple animal. The change in expression of every predicted gene in the genome can be quantified under defined experimental conditions using DNA microarrays, thus providing a ”molecular signature“ of particular developmental processes. Because DNA microarray analysis does not rely upon detection of a gross morphological phenotype, genes whose function escapes identification in mutation screens can now be associated with different developmental processes. Together, C. elegans and DNA microarrays are a powerful combination with which to attack complex problems in developmental biology and work toward a more complete understanding of the underlying genetic networks governing development.
Keywords: Gene expression profiling, Functional genomics, clustering, microarrays
Current Genomics
Title: Defining Development Through Gene Expression Profiling
Volume: 3 Issue: 2
Author(s): Valerie Reinke
Affiliation:
Keywords: Gene expression profiling, Functional genomics, clustering, microarrays
Abstract: For an ever-increasing number of species, the completed genomic sequence is available, providing a means to identify all the genes encoded in a genome. The functional relationships between these genes must be defined in order to generate a cohesive understanding of the molecular events that direct metazoan development. The model organism C. elegans, with its completed genomic sequence, defined cell lineage and robust genetics, provides an excellent opportunity to reconstruct the genetic relationships that underlie the development of a relatively simple animal. The change in expression of every predicted gene in the genome can be quantified under defined experimental conditions using DNA microarrays, thus providing a ”molecular signature“ of particular developmental processes. Because DNA microarray analysis does not rely upon detection of a gross morphological phenotype, genes whose function escapes identification in mutation screens can now be associated with different developmental processes. Together, C. elegans and DNA microarrays are a powerful combination with which to attack complex problems in developmental biology and work toward a more complete understanding of the underlying genetic networks governing development.
Export Options
About this article
Cite this article as:
Reinke Valerie, Defining Development Through Gene Expression Profiling, Current Genomics 2002; 3 (2) . https://dx.doi.org/10.2174/1389202024605215
DOI https://dx.doi.org/10.2174/1389202024605215 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Deep learning in Single Cell Analysis
The field of biology is undergoing a revolution in our ability to study individual cells at the molecular level, and to integrate data from multiple sources and modalities. This has been made possible by advances in technologies for single-cell sequencing, multi-omics profiling, spatial transcriptomics, and high-throughput imaging, as well as ...read more
New insights on Pediatric Tumors and Associated Cancer Predisposition Syndromes
Because of the broad spectrum of children cancer susceptibility, the diagnosis of cancer risk syndromes in children is rarely used in direct cancer treatment. The field of pediatric cancer genetics and genomics will only continue to expand as a result of increasing use of genetic testing tools. It's possible that ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Targeted Drug Delivery System for Platinum-based Anticancer Drugs
Mini-Reviews in Medicinal Chemistry MicroRNA Therapeutics: the Next Magic Bullet?
Mini-Reviews in Medicinal Chemistry Antisense Treatment in Human Prostate Cancer and Melanoma
Current Cancer Drug Targets Glycolipid Stimulators for NKT Cells Bearing Invariant Vα19-Jα33 TCR α Chains
Mini-Reviews in Medicinal Chemistry Anaplastic Lymphoma Kinase Inhibitors in Non-Small Cell Lung Cancer
Current Drug Targets The Biology of TRAIL and the Role of TRAIL-Based Therapeutics in Infectious Diseases
Anti-Infective Agents in Medicinal Chemistry Advanced Microfluorescence Methods in Monitoring Intracellular Uptake of “Antisense” Oligonucleotides
Current Organic Chemistry Biomarkers and Multiple Drug Resistance in Breast Cancer
Current Cancer Drug Targets Gene Therapy of Cancer with Interleukin-12
Current Pharmaceutical Design The Metabolism of Anticancer Drugs by the Liver: Current Approaches to the Drug Development Process
Current Drug Metabolism Molecular Mechanisms Regulating Matrix Metalloproteinases
Current Topics in Medicinal Chemistry Preparation and Quality Control of <sup>111</sup>In-Plerixafor for Chemokine Receptor CXCR4
Recent Patents and Topics on Imaging (Discontinued) 5-Aminoisoquinolin-1-one (5-AIQ), a Water-Soluble Inhibitor of the Poly(ADP-Ribose)Polymerases (PARPs)
Current Medicinal Chemistry Cancer Immunotherapy: The Role Regulatory T Cells Play and What Can be Done to Overcome their Inhibitory Effects
Current Molecular Medicine Innate T-Cell Immunity in HIV Infections: The Role of Vg9Vd2 T Lymphocytes
Current Molecular Medicine Design, Synthesis and Biological Evaluation of Cyanopyridines, Pyridopyrazolopyrimidines and Pyridopyrazolotriazines as Potential Anticancer Agents
Current Organic Synthesis The Potential of Flavonoids and Tannins from Medicinal Plants as Anticancer Agents
Anti-Cancer Agents in Medicinal Chemistry Improving Functional Modules Discovery by Enriching Interaction Networks with Gene Profiles
Current Bioinformatics Therapeutic Peptide Mimetics Looking for a Turn to Block Aberrant Players of Malignancy
Current Cancer Therapy Reviews Signal Pathways and Therapeutic Prospects of Diffuse Large B Cell Lymphoma
Anti-Cancer Agents in Medicinal Chemistry